Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Accelerometry-based assessment of physical activity and sedentary behavior in adult survivors of childhood acute lymphoblastic leukemia and their healthy peers

T. Vyhlídal, J. Dygrýn, J. Hrubá, F. Chmelík

. 2023 ; 13 (1) : 7439. [pub] 20230508

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Adult survivors of childhood acute lymphoblastic leukemia (ASALL) compose a specific group that faces an increased risk of experiencing late effects of their earlier treatment. Physical activity (PA) may be one of the appropriate means for preventing or minimizing the late effects of treatment. The main purpose of this study is to characterize device-measured PA and sedentary behavior (SB) among ASALL. The specific objective was to compare the movement behavior with a group recruited from the healthy population and to determine the degree of compliance with health recommendations for PA in the adult population. Twenty ASALL and 21 healthy control group (CG) members participated in the study. Participants were between 18 and 30 years old. Movement behavior was assessed for seven days using an Axivity AX3 accelerometer and a 24-h wearing protocol. Movement behavior was characterized by the amount of time spent in SB, light PA (LPA), moderate PA (MPA), and vigorous PA (VPA). There were no significant differences in movement behavior or compliance with PA recommendations between the ASALL and CG. During the week, the ASALL accumulated 711 min per day of SB vs. 636 min per day in the CG (p = 0.26); the ASALL had 186 min per day of LPA vs. 201 min per day in the CG (p = 0.47); the ASALL had 132 min per day of MPA vs. 147 min per day in the CG (p = 0.25); and the ASALL had 5 min per day of VPA vs. 4 min per day in the CG (p = 0.48). All research participants (ASALL and CG) met the PA recommendations of > 150 min per week for moderate PA. The results of our study suggest that ASALL, even after suffering from that disease in childhood, display comparable levels of PA and SB to their healthy peers. Both groups met the health recommendations for PA. The device-based monitoring of PA and SB should be an integral part of monitoring the late effects of treatment.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23011472
003      
CZ-PrNML
005      
20230801133054.0
007      
ta
008      
230718s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41598-023-34689-5 $2 doi
035    __
$a (PubMed)37156849
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Vyhlídal, Tomáš $u Faculty of Physical Culture, Palacký University Olomouc, třída Míru 117, 771 11, Olomouc, Czech Republic. tomas.vyhlidal@upol.cz $1 https://orcid.org/0000000185269524
245    10
$a Accelerometry-based assessment of physical activity and sedentary behavior in adult survivors of childhood acute lymphoblastic leukemia and their healthy peers / $c T. Vyhlídal, J. Dygrýn, J. Hrubá, F. Chmelík
520    9_
$a Adult survivors of childhood acute lymphoblastic leukemia (ASALL) compose a specific group that faces an increased risk of experiencing late effects of their earlier treatment. Physical activity (PA) may be one of the appropriate means for preventing or minimizing the late effects of treatment. The main purpose of this study is to characterize device-measured PA and sedentary behavior (SB) among ASALL. The specific objective was to compare the movement behavior with a group recruited from the healthy population and to determine the degree of compliance with health recommendations for PA in the adult population. Twenty ASALL and 21 healthy control group (CG) members participated in the study. Participants were between 18 and 30 years old. Movement behavior was assessed for seven days using an Axivity AX3 accelerometer and a 24-h wearing protocol. Movement behavior was characterized by the amount of time spent in SB, light PA (LPA), moderate PA (MPA), and vigorous PA (VPA). There were no significant differences in movement behavior or compliance with PA recommendations between the ASALL and CG. During the week, the ASALL accumulated 711 min per day of SB vs. 636 min per day in the CG (p = 0.26); the ASALL had 186 min per day of LPA vs. 201 min per day in the CG (p = 0.47); the ASALL had 132 min per day of MPA vs. 147 min per day in the CG (p = 0.25); and the ASALL had 5 min per day of VPA vs. 4 min per day in the CG (p = 0.48). All research participants (ASALL and CG) met the PA recommendations of > 150 min per week for moderate PA. The results of our study suggest that ASALL, even after suffering from that disease in childhood, display comparable levels of PA and SB to their healthy peers. Both groups met the health recommendations for PA. The device-based monitoring of PA and SB should be an integral part of monitoring the late effects of treatment.
650    _2
$a lidé $7 D006801
650    _2
$a dospělí $7 D000328
650    _2
$a mladiství $7 D000293
650    _2
$a mladý dospělý $7 D055815
650    12
$a sedavý životní styl $7 D057185
650    _2
$a cvičení $7 D015444
650    _2
$a zdravotní stav $7 D006304
650    _2
$a akcelerometrie $7 D061725
650    12
$a akutní lymfatická leukemie $x terapie $7 D054198
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Dygrýn, Jan $u Faculty of Physical Culture, Palacký University Olomouc, třída Míru 117, 771 11, Olomouc, Czech Republic $1 https://orcid.org/0000000310261784 $7 xx0230570
700    1_
$a Hrubá, Jaroslava $u Faculty of Physical Culture, Palacký University Olomouc, třída Míru 117, 771 11, Olomouc, Czech Republic $1 https://orcid.org/0000000179604939
700    1_
$a Chmelík, František $u Faculty of Physical Culture, Palacký University Olomouc, třída Míru 117, 771 11, Olomouc, Czech Republic $1 https://orcid.org/0000000257583783 $7 xx0119339
773    0_
$w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 13, č. 1 (2023), s. 7439
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37156849 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230718 $b ABA008
991    __
$a 20230801133051 $b ABA008
999    __
$a ok $b bmc $g 1963718 $s 1197737
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 13 $c 1 $d 7439 $e 20230508 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
LZP    __
$a Pubmed-20230718

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...